Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00185991 · ClinicalTrials.gov registry record · NA
Comparison of Once Daily Versus 8 Hour Dosing of Gentamicin for the Treatment of Intrapartum Chorioamnionitis
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 126
- Enrollment target
NCT00185991: Completed NA study, sponsored by Stanford University.
NCT00185991 is a NA study that has completed, run by Stanford University. The registered enrollment target is 126 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00185991, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 126 participants
- Enrollment target
Study Summary
To compare once daily versus 8 hour dosing of gentamicin for the treatment of chorioamnionitis.
Interventions
- DRUG gentamicin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2004-06 |
| Est. Completion | 2010-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00185991
The ClinicalTrials.gov registry entry for NCT00185991 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which gentamicin is the first listed.
NCT00185991 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00185991 about?
NCT00185991 is a clinical study titled "Comparison of Once Daily Versus 8 Hour Dosing of Gentamicin for the Treatment of Intrapartum Chorioamnionitis". To compare once daily versus 8 hour dosing of gentamicin for the treatment of chorioamnionitis.
What is the current status of trial NCT00185991?
This trial is currently completed. It is a NA study. The enrollment target is 126 participants. The study started on 2004-06. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00185991?
The interventions under investigation include: gentamicin (DRUG).
Who is sponsoring clinical trial NCT00185991?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.